Exagen Inc. SEC filings XGN
Exagen Inc. has 421 filings in SEC EDGAR's recent list, going back to Dec 29, 2003. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 4, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jul 2, 2025 | — |
| CORRESP | Letter to the SEC | Jun 30, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 30, 2025 | — |
| EFFECT | Filing | Nov 29, 2023 | — |
| CORRESP | Letter to the SEC | Nov 28, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 22, 2023 | — |
| NT 10-Q | Filing | Nov 14, 2022 | Nov 14, 2022 |
| EFFECT | Filing | Nov 19, 2020 | — |
| CORRESP | Letter to the SEC | Nov 17, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 16, 2020 | — |
| EFFECT | Filing | Sep 18, 2019 | — |
| CERT | Filing | Sep 17, 2019 | — |
| CORRESP | Letter to the SEC | Sep 16, 2019 | — |
| CORRESP | Letter to the SEC | Sep 16, 2019 | — |
| 8-A12B | Filing | Sep 13, 2019 | — |
| CORRESP | Letter to the SEC | Aug 26, 2019 | — |
| DRSLTR | Filing | Jun 14, 2019 | — |
| DRS/A | Filing | Jun 14, 2019 | — |
| UPLOAD | Letter from the SEC | Feb 27, 2019 | — |
| DRS | Filing | Feb 1, 2019 | — |
| D | Filing | Feb 1, 2019 | — |
| D | Filing | May 18, 2017 | — |
| D | Filing | Apr 10, 2017 | — |
| D | Filing | Mar 9, 2017 | — |
| D | Filing | Feb 1, 2017 | — |
| D | Filing | Dec 19, 2016 | — |
| D | Filing | Nov 10, 2016 | — |
| D | Filing | Oct 11, 2016 | — |
| D | Filing | Aug 30, 2016 | — |
| D | Filing | Jun 24, 2016 | — |
| D | Filing | Jan 26, 2016 | — |
| D | Filing | Oct 21, 2015 | — |
| D | Filing | Jul 6, 2015 | — |
| D | Filing | Apr 1, 2015 | — |
| DRS | Filing | Aug 4, 2014 | — |
| D | Filing | Jul 21, 2014 | — |
| D | Filing | Oct 15, 2013 | — |
| D | Filing | Nov 1, 2012 | — |
| D | Filing | Sep 11, 2012 | — |
| D | Filing | Dec 22, 2011 | — |
| D | Filing | Nov 18, 2011 | — |
| D | Filing | Sep 27, 2011 | — |
| D | Filing | Jun 29, 2011 | — |
| D/A | Filing | May 11, 2011 | — |
| D | Filing | Oct 25, 2010 | — |
| D | Filing | May 26, 2009 | — |
| REGDEX | Auto-generated paper document | Jul 24, 2008 | — |
| REGDEX | Auto-generated paper document | Apr 23, 2008 | — |
| REGDEX | Auto-generated paper document | Oct 19, 2007 | — |
| REGDEX | Auto-generated paper document | Feb 24, 2006 | — |
| REGDEX | Auto-generated paper document | Jul 11, 2005 | — |
| REGDEX | Auto-generated paper document | Dec 29, 2003 | — |
Showing 52 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- XGN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Vista, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1274737
- Former names
- EXAGEN DIAGNOSTICS INC (until May 18, 2017)
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.